Literature DB >> 32321110

Use of smartphone-based instant messaging services in medical practice: a cross-sectional study.

Israel Junior Borges do Nascimento1, João Antonio de Queiroz Oliveira2, Iago Souza Wolff3, Laura Defensor Ribeiro3, Maíra Viana Rego Souza E Silva3, Clareci Silva Cardoso4, Maurice Mars5, Antonio Luiz Ribeiro6, Milena Soriano Marcolino7.   

Abstract

BACKGROUND: Instant messaging services (IMS) are widely used in medical practice.
OBJECTIVE: To evaluate perceptions regarding use and usability of IMS within clinical practice and assess users' knowledge of the ethical and legal context involved in using IMS within medical practice. DESIGN AND
SETTING: Cross-sectional study conducted in different hospitals and medical institutions in Minas Gerais, Brazil.
METHODS: Medical students, medical residents, primary care physicians and specialist doctors answered an online questionnaire regarding epidemiological data, graduation level and use of IMS for medical communication. Responses were collected over a five-month period and data were assessed using the IBM-SPSS software.
RESULTS: 484 people answered the questionnaire: 97.0% declared that they were using IMS for medical-related purposes; 42.0%, to elucidate medical concerns every week; 75.0%, to share imaging or laboratory tests and patients' medical records; and 90.5%, to participate in clinical case-study private groups. Moreover, only 37.0% declared that they had knowledge of the legislative aspects of use of smartphones within clinical practice. Differences in the frequency of discussion of medical concerns within the daily routine between student/residents and general practitioners/specialists, and in the frequency of image-sharing and patient-guiding/assistance between students and medical doctors, were observed.
CONCLUSIONS: Our results provide reliable proof that medical doctors and students use IMS, as a tool for clinical case discussions, interactions between healthcare providers and patients, or dissemination of knowledge and information. Nonetheless, because of limitations to the ethical and legal regulations, evidence-based discussions between authorities, academics and medical institutions are needed in order to fully achieve positive outcomes from such platforms.

Entities:  

Mesh:

Year:  2020        PMID: 32321110     DOI: 10.1590/1516-3180.2020.0010.R1.28032020

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  6 in total

1.  Development and validation of a Smartphone Impact Scale among healthcare professionals.

Authors:  Tahani N Altamimi; Johnson Alex; Moizuddin M Khan; Binu V S Nair
Journal:  J Taibah Univ Med Sci       Date:  2020-08-21

2.  Smart-phone based telemedicine: Instant messaging application as a platform for radiographic interpretations of jaw pathologies.

Authors:  Medhini Madi; Mathangi Kumar; Kalyana Chakravarthy Pentapati; Ravindranath Vineetha
Journal:  J Oral Biol Craniofac Res       Date:  2021-04-14

Review 3.  Netiquette: Ethic, Education, and Behavior on Internet-A Systematic Literature Review.

Authors:  Rebeca Soler-Costa; Pablo Lafarga-Ostáriz; Marta Mauri-Medrano; Antonio-José Moreno-Guerrero
Journal:  Int J Environ Res Public Health       Date:  2021-01-29       Impact factor: 3.390

4.  Use of Instant Messaging Software in a German Hospital-An Exploratory Investigation among Physicians.

Authors:  Sabine Sayegh-Jodehl; Rebecca Mukowski-Kickhöfel; Diane Linke; Claudia Müller-Birn; Matthias Rose
Journal:  Int J Environ Res Public Health       Date:  2022-10-02       Impact factor: 4.614

Review 5.  Telemedicine improves mental health in COVID-19 pandemic.

Authors:  Md Yeasin Arafat; Sanjana Zaman; Mohammad Delwer Hossain Hawlader
Journal:  J Glob Health       Date:  2021-03-07       Impact factor: 4.413

Review 6.  WhatsApp in Clinical Practice-The Challenges of Record Keeping and Storage. A Scoping Review.

Authors:  Christopher Morris; Richard E Scott; Maurice Mars
Journal:  Int J Environ Res Public Health       Date:  2021-12-20       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.